A class-action suit was filed in the U.S. District Court of Arizona alleging that CareMark Rx, Inc. intentionally concealed revenue in order to avoid paying certain commissions owed to consultants who marketed and sold its services.
According to the complaint, CareMark engages consultants to market and sell its services to health plan sponsors and plan participants. If an entity contracts with CareMark to use its pharmaceutical services, the consultant is entitled to either a percentage of the total revenue -- including administrative fees -- or a set rate for each drug purchased.
The complaint states that CareMark failed to honor the plain language of the consulting contracts by not paying commission based on total revenues and instead paying commission based on only partial revenues.
According to named plaintiff Jan Peck, CareMark intentionally failed to report total revenues earned from four companies she brought to two of CareMark's predecessors.
"I brought a great deal of business to companies Caremark purchased, and Caremark did its best to under-report that revenue, knowing it would affect my commissions," said Peck. "CareMark negotiated new contracts with the customers and then hid the revenue as separate administrative fees." Peck estimates she is owed between $25 and $50 million in under-reported revenue commission.
Allegations against Caremark include, among other things, breach of contract, breach of good faith and fair dealings, and misrepresentation. The proposed class-action suit includes all persons who contracted with CareMark -- or any entity acquired by CareMark -- to sell or market formulary services whose compensation was based on a percentage of revenue generated by clients they brought to CareMark or its predecessors, received a set rate for each qualifying drug purchased by these companies, or a combination of both methods.
The suit seeks compensatory and punitive damages, interest on all owed money to members of the class, and a release of all revenue information earned under the consulting agreement.